CALIX, INC·4

Sep 11, 6:33 PM ET

Weening Michael 4

4 · CALIX, INC · Filed Sep 11, 2025

Insider Transaction Report

Form 4
Period: 2025-09-10
Weening Michael
DirectorPresident & CEO
Transactions
  • Exercise/Conversion

    Stock Option (right to buy)

    2025-09-107,990292,010 total
    Exercise: $7.84Exp: 2029-11-27Common Stock (7,990 underlying)
  • Exercise/Conversion

    Common Stock

    2025-09-10$7.84/sh+7,990$62,64224,107 total
  • Exercise/Conversion

    Common Stock

    2025-09-10$7.84/sh+150,000$1,176,000166,117 total
  • Sale

    Common Stock

    2025-09-10$62.00/sh150,000$9,300,00016,117 total
  • Sale

    Common Stock

    2025-09-10$63.00/sh7,990$503,37016,117 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2025-09-10150,000300,000 total
    Exercise: $7.84Exp: 2029-11-27Common Stock (150,000 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2025-09-1118,010274,000 total
    Exercise: $7.84Exp: 2029-11-27Common Stock (18,010 underlying)
  • Exercise/Conversion

    Common Stock

    2025-09-11$7.84/sh+18,010$141,19834,127 total
  • Sale

    Common Stock

    2025-09-11$63.00/sh18,010$1,134,63016,117 total
Footnotes (1)
  • [F1]100% of the shares subject to the option were fully vested and exercisable on November 27, 2023.

Documents

1 file
  • 4
    wk-form4_1757629976.xmlPrimary

    FORM 4